KU13
KU13 is an inhibitor of nontuberculous mycobacteria (NTM). The minimum inhibitory concentrations (MIC) of KU13 against Mycobacterium and E. coli are 0.032-8 μg/mL and 2 μg/mL, respectively. KU13 can be used for research in the field of anti-infection .
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3066104-44-4
- Fòrmula: C58H92N6O17
- Peso molecular:1145.38
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas Antibiotic
More
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 3066104-44-4
-
Peso molecular 1145.38
-
Fòrmula C58H92N6O17
-
SMILES
O[C@H]1[C@@H]([C@H](O[C@@H]([C@@H]1O)O[C@@H]([C@@](C)([C@H](OC2=O)CC)O)[C@H](N(C[C@@H](C[C@@](O)([C@@H]([C@H]([C@@H]([C@H]2C)O[C@@H]3O[C@H]([C@@H]([C@@](C)(C3)OC)O)C)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)C)C)C)C)CO)OCC5=CC=C(C=C5)N6C=C(N=N6)C7=CC=NC=C7
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
KU13 Related Classifications
HY-172263 Related Classifications
Powered by Bioz